Immunotherapy and Cancer: Harnessing the Power of Diagnostic Assays

In this eBook learn how MolecularMD is harnessing the company's unique capabilities to address diagnostic needs within immuno-oncology.
coronavirus

Genomic Applications in the Fight against SARS-CoV-2

In this Keynote Webinar, sponsored by Illumina, two leading researchers will show how genomic technologies are tackling the COVID-19 pandemic—Alex Greninger, MD, PhD, (University of Washington School of Medicine) and Darrell Dinwiddie PhD, (University of New Mexico Health Sciences Center).

Conquering CML: The Breakthrough Paradigm Change of Treatment-free Remission

Download this eBook to learn how MolecularMD helped usher in a new era of CML treatment now prescribed by progressive clinicians.
Clinical OMICs Keynote Webinar lead image

Newborn Genomic Screening: In Sickness and In Health

In this inaugural Clinical OMICs Keynote webinar, we are proud to host two renowned leaders in the field of genomic medicine, Drs Stephen Kingsmore and Robert Green, who will discuss their pioneering work in the field of newborn genome sequencing and analysis.
Qiagen eBook lead image

Unlocking the Cancer Code

In this eBook, sponsored by Qiagen, we explore the opportunities and challenges of precision oncology and how molecular profiling is fundamental not only to inform on tumor diagnosis and prognosis, but also to drive therapeutic decisions in routine clinical care.

Advancing Mass Spectrometry-Based Large-Cohort Proteomics for Precision Medicine

Large cohort studies are essential to the discovery of protein biomarkers, and their validation is indispensable to clinical utility.
video

Detection of Ovarian Cancer Recurrence: Quality Control Routines using an Integrated Proteomics Approach

The webinar will focus on some of the current challenges facing researchers looking to improve biomarker discovery for ovarian cancer.

Cancer Gene Variant Detection Using a Pre-Optimized Sample to Report Workflow

REGISTER NOW Broadcast Date: September 12, 2019 Time: 8:00 am PT, 11:00 am ET, 17:00 CET BRCA1/BRCA2 genes represent the best examples for our current understanding of...
Researchers Operating Chemistry Analyzer Machine

Better Understanding of Post-Translation Modifications Driving Innovation

Takeda has taken great strides in incorporating a patient-centric approach to drug development through the use of minimally invasive and less frequent testing procedures while maintaining the power and rigor of the clinical trial.

LeukoVantage: A Quest/QIAGEN Partnership Providing Clinical Insights Into Myeloid Malignancies

In this webinar, we will describe Quest’s LeukoVantage assay, an NGS test designed specifically for detecting clinically relevant variants in myeloid malignancies, and its partnership with N-of-One, a QIAGEN company, for expert interpretation.

Featured

Scroll Up